newsfilter
← Latest News
Business Wire·

Nortiva Bio Launches to Develop Long-Acting Oral Medicines

Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that last for up to a month, including a monthly oral contraceptive Company seeks pipeline expansion via industry